Novacyt H1 Loss Narrows As Revenue Rises 18%
(RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services, reported higher revenue and a narrower loss for the six months ended June 30, 2026.
Los artículos de esta sección se muestran en inglés.
Novacyt H1 Loss Narrows As Revenue Rises 18%
Desk de Trade News (2026-10-01): Novacyt H1 Loss Narrows As Revenue Rises 18% (RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services,… Fuente primaria: original en Nasdaq Market Structure (nasdaq.com).